NF-kappa B in Murine Sepsis

小鼠脓毒症中的 NF-kappa B

基本信息

  • 批准号:
    7003964
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Excessive release of inflammatory mediators contributes directly to the pathogenesis of organ injury and death occurring during severe infection complicated by sepsis and septic shock. Nuclear factor kappa B (NF-kB) is a nuclear transcription regulatory protein central to the activation of several different genes encoding proteins associated with the inflammatory response during sepsis. Under normal conditions, NF-kB remains sequestered in an inactive state in the cytoplasm under the control of its cytoplasmic inhibitor (I-(B) proteins. However, differing kinds of stimuli including LPS (the toxic moiety of gram-negative bacteria) and cytokines (e.g. TNF alpha and interleukin-6) cause the phosphorylation, ubiquitinylation, and the subsequent degradation of I-kB proteins in turn resulting in the activation of NF-kB. Then the DNA-binding subunits of NF-kB migrate into the nucleus and activate expression of target genes that code for proteins in the inflammatory and immune responses, such as chemokines, cytokines, inducible nitric oxide synthase (iNOS), and adhesion molecules. Many of these gene products have been closely associated with the pathogenesis of the hemodynamic instability and organ injury occurring during sepsis and septic shock. Therefore, agents designed to inhibit NF-kB may have broad antiinflammmatory effects that could be beneficial during sepsis. However, many of the host mediators associated with the inflammatory response and under the control of NF-kB also contribute to innate immunity and the clearance of bacterial infection. Suppression of NF-kB during sepsis could therefore also worsen underlying infection. The present protocol tests the effects of agents designed to modulate NF-kB in a murine model of sepsis. The first agent under investigation is parthenolide. Parthenolide is a sesquiterpene lactone derived from Asteraceae plants. Parthenolide has been reported to improve survival when administered up to 3 hours following intravenous LPS stimulation in mice or rats challenged with intraperitoneal or intravenous LPS respectively. However in the investigations that have thus far been completed in a fluid supported mouse model under this protocol, inhibition of NF-KB with parthenolide has been harmful with LPS challenge. These results emphasize the potential protective effect NF-KB has in host defense against microbial toxins. Work in this project is now centered on investigating tissue expression of NF-kB over the time following LPS challenge. Thus far, studies in the lung have shown that NF-kB expression is related to the dose of LPS challenge. Furthermore, parthenolide?s effects on NF-kB expression appear to be time dependent. Although levels are decreased early, they are increased late after LPS challenge with parthenolide. These changes are now being investigated in other tissues. In addition, the relationship between these changes in tissue NF-kB expression are being correlated to changes in plasma cytokine levels.
在严重感染并发脓毒症和脓毒性休克时,炎症介质的过度释放直接导致器官损伤和死亡。核因子κ B(NF-κ B)是一种核转录调节蛋白,其对脓毒症期间编码与炎症反应相关的蛋白质的几种不同基因的激活起核心作用。在正常条件下,NF-κ B在其胞质抑制剂(I-(B))蛋白的控制下保持在胞质中的无活性状态。然而,包括LPS(革兰氏阴性细菌的毒性部分)和细胞因子(例如TNF α和白细胞介素-6)的不同种类的刺激引起I-kB蛋白的磷酸化、泛素化和随后的降解,进而导致NF-κ B的活化。然后,NF-kB的DNA结合亚基迁移到细胞核中,并激活编码炎症和免疫反应中蛋白质的靶基因的表达,例如趋化因子、细胞因子、诱导型一氧化氮合酶(iNOS)和粘附分子。这些基因产物中的许多与脓毒症和脓毒性休克期间发生的血流动力学不稳定和器官损伤的发病机制密切相关。因此,旨在抑制NF-κ B的药物可能具有广泛的抗炎作用,这在脓毒症期间可能是有益的。然而,许多与炎症反应相关并受NF-κ B控制的宿主介质也有助于先天免疫和细菌感染的清除。因此,脓毒症期间NF-kB的抑制也可能使基础感染恶化。 本方案测试了设计用于调节NF-κ B的药剂在脓毒症鼠模型中的作用。第一个被调查的探员是帕滕森。银胶菊是一种来源于菊科植物的倍半萜内酯。据报道,在分别用腹膜内或静脉内LPS激发的小鼠或大鼠中,当在静脉内LPS刺激后长达3小时施用孤雌菊时,孤雌菊可改善存活率。然而,在迄今为止根据该方案在液体支持的小鼠模型中完成的研究中,用孤雌菊抑制NF-κ B对于LPS攻击是有害的。这些结果强调了NF-κ B在宿主防御微生物毒素中的潜在保护作用。 该项目的工作现在集中在研究LPS激发后随时间推移NF-κ B的组织表达。到目前为止,在肺中的研究表明,NF-κ B的表达与LPS攻击的剂量有关。此外,parthenopsis?对NF-κ B表达的影响呈时间依赖性。虽然水平降低早期,他们增加后,LPS攻击与孤雌生殖器。目前正在其他组织中研究这些变化。此外,组织NF-κ B表达的这些变化之间的关系与血浆细胞因子水平的变化相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Q Eichacker其他文献

Peter Q Eichacker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Q Eichacker', 18)}}的其他基金

Effects of Therapeutic Recombinant Granulocyte Colony Stimulating Factor
治疗性重组粒细胞集落刺激因子的作用
  • 批准号:
    6227873
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TYROSINE KINASE INHIBITION IN A CANINE MODEL OF S. AUREUS INFECTION
犬金黄色葡萄球菌感染模型中酪氨酸激酶的抑制
  • 批准号:
    6289408
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TYPE OF INFECTION ON EFFECTS OF ENDOTOXIN ANALOG
感染类型对内毒素类似物的影响
  • 批准号:
    6414070
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Influence Of Systemic Inflammation On The Effects Of Rec
全身炎症对 Rec 效果的影响
  • 批准号:
    6546515
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Site,severity& Infection Type Influence On Superoxide Di
地点、严重程度
  • 批准号:
    6825056
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Influence Of Site, Severity, And Type Of Infection On Ef
感染部位、严重程度和类型对 Ef 的影响
  • 批准号:
    6993911
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Pretreatment Sublethal B. Anthracis Lethal Toxin in Rats
预处理大鼠亚致死炭疽杆菌致死毒素
  • 批准号:
    7003993
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Site,severity& Infection Type Influence On Superoxide Di
地点、严重程度
  • 批准号:
    6683812
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NF-kappa B in Murine Sepsis
小鼠脓毒症中的 NF-kappa B
  • 批准号:
    7215794
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PA-mAb in a Rat Model of Anthrax Sepsis
PA-mAb 在炭疽脓毒症大鼠模型中的作用
  • 批准号:
    7215804
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了